Loading...
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)
BACKGROUND: Delayed-release dimethyl fumarate (DMF) demonstrated efficacy and safety in the Phase 3 DEFINE and CONFIRM trials. OBJECTIVE: To evaluate delayed-release DMF in newly diagnosed relapsing–remitting multiple sclerosis (RRMS) patients, in a post-hoc analysis of integrated data from DEFINE a...
Na minha lista:
| Udgivet i: | Mult Scler |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361464/ https://ncbi.nlm.nih.gov/pubmed/24990854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458514537013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|